BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36099446)

  • 1. Computer-Aided Design of Lasso-like Self-Assembling Anticancer Peptides with Multiple Functions for Targeted Self-Delivery and Cancer Treatments.
    Pei P; Chen L; Fan R; Zhou XR; Feng S; Liu H; Guo Q; Yin H; Zhang Q; Sun F; Peng L; Wei P; He C; Qiao R; Wang Z; Luo SZ
    ACS Nano; 2022 Sep; 16(9):13783-13799. PubMed ID: 36099446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembling branched amphiphilic peptides for targeted delivery of small molecule anticancer drugs.
    Chen J; Wang W; Wang Y; Yuan X; He C; Pei P; Su S; Zhao W; Luo SZ; Chen L
    Eur J Pharm Biopharm; 2022 Oct; 179():137-146. PubMed ID: 36096399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first integrins β3-mediated cellular and nuclear targeting therapeutics for prostate cancer.
    Zhang L; Shan X; Meng X; Gu T; Lu Q; Zhang J; Chen J; Jiang Q; Ning X
    Biomaterials; 2019 Dec; 223():119471. PubMed ID: 31525693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug.
    Jiang X; Fan X; Xu W; Zhao C; Wu H; Zhang R; Wu G
    J Control Release; 2019 Dec; 316():196-207. PubMed ID: 31682910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Delivery of Dual Anticancer Drugs Based on Self-Assembled iRGD-Modified Soluble Drug-Polymer Pattern Conjugate Nanoparticles.
    Li C; Chen Z; Zheng D; Zhao J; Lei J
    ACS Appl Bio Mater; 2021 Feb; 4(2):1499-1507. PubMed ID: 35014499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy.
    Gong Z; Liu X; Zhou B; Wang G; Guan X; Xu Y; Zhang J; Hong Z; Cao J; Sun X; Gao Z; Lu H; Pan X; Bai J
    Colloids Surf B Biointerfaces; 2021 Jun; 202():111673. PubMed ID: 33714186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics.
    Lin CJ; Kuan CH; Wang LW; Wu HC; Chen Y; Chang CW; Huang RY; Wang TW
    Biomaterials; 2016 Jun; 90():12-26. PubMed ID: 26974704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
    Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
    Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery.
    Xiao D; Jia HZ; Ma N; Zhuo RX; Zhang XZ
    Nanoscale; 2015 Jun; 7(22):10071-7. PubMed ID: 25978679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiating the Anticancer Properties of Bisphosphonates by Nanocomplexation with the Cationic Amphipathic Peptide, RALA.
    Massey AS; Pentlavalli S; Cunningham R; McCrudden CM; McErlean EM; Redpath P; Ali AA; Annett S; McBride JW; McCaffrey J; Robson T; Migaud ME; McCarthy HO
    Mol Pharm; 2016 Apr; 13(4):1217-28. PubMed ID: 26954700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy.
    Cheng K; Ding Y; Zhao Y; Ye S; Zhao X; Zhang Y; Ji T; Wu H; Wang B; Anderson GJ; Ren L; Nie G
    Nano Lett; 2018 May; 18(5):3250-3258. PubMed ID: 29683683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.
    Liang Y; Li S; Wang X; He B; He B; Dai W; Zhang H; Wang X; Wang Y; Zhou D; Zhang Q
    Theranostics; 2017; 7(13):3306-3318. PubMed ID: 28900511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
    Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.
    Hong ST; Lin H; Wang CS; Chang CH; Lin AM; Yang JC; Lo YL
    J Nanobiotechnology; 2019 Aug; 17(1):89. PubMed ID: 31426807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Watson-Crick G[triple bond, length as m-dash]C"-inspired supramolecular nanodrug of methotrexate and 5-fluorouracil for tumor microenvironment-activatable self-recognizing synergistic chemotherapy.
    Chen M; Chen S; Zhu F; Wang F; Tian H; Fan Z; Ke S; Hou Z; Li Y
    J Mater Chem B; 2020 May; 8(17):3829-3841. PubMed ID: 32232285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.